Interestingly, while the PD-L1/PD-1 signaling pathway is abundantly engaged in the TME, expression of PD-1 on peripheral CD4+ and CD8+ T cells has been shown to increase with tumor progression [142]. This evidence concerns the gene CD8A and neoplasm.